Meissa Vaccines enters into CGMP manufacturing agreement for pediatric RSV vaccine candidate for Phase 2 clinical trials
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Subscribe To Our Newsletter & Stay Updated